ISSN: 2249-9504
CAS CODEN: IJPCDX

Abstracted and Indexed

open access publisher, open access publishing, open access journals and articles, peer reviewed open access journals, insight medical publishing open access publisher, open access publishing, open access journals and articles, peer reviewed open access journals, insight medical publishing open access publisher, open access publishing, open access journals and articles, peer reviewed open access journals, insight medical publishing open access publisher, open access publishing, open access journals and articles, peer reviewed open access journals, insight medical publishing open access publisher, open access publishing, open access journals and articles, peer reviewed open access journals, insight medical publishing open access publisher, open access publishing, open access journals and articles, peer reviewed open access journals, insight medical publishing open access publisher, open access publishing, open access journals and articles, peer reviewed open access journals, insight medical publishing open access publisher, open access publishing, open access journals and articles, peer reviewed open access journals, insight medical publishing open access publisher, open access publishing, open access journals and articles, peer reviewed open access journals, insight medical publishing open access publisher, open access publishing, open access journals and articles, peer reviewed open access journals, insight medical publishing open access publisher, open access publishing, open access journals and articles, peer reviewed open access journals, insight medical publishing open access publisher, open access publishing, open access journals and articles, peer reviewed open access journals, insight medical publishing open access publisher, open access publishing, open access journals and articles, peer reviewed open access journals, insight medical publishing open access publisher, open access publishing, open access journals and articles, peer reviewed open access journals, insight medical publishing open access publisher, open access publishing, open access journals and articles, peer reviewed open access journals, insight medical publishing open access publisher, open access publishing, open access journals and articles, peer reviewed open access journals, insight medical publishing open access publisher, open access publishing, open access journals and articles, peer reviewed open access journals, insight medical publishing open access publisher, open access publishing, open access journals and articles, peer reviewed open access journals, insight medical publishing open access publisher, open access publishing, open access journals and articles, peer reviewed open access journals, insight medical publishing open access publisher, open access publishing, open access journals and articles, peer reviewed open access journals, insight medical publishing
+32 25889658
Google Scholar citation report
Citations : 3566

International Journal of Pharmaceutical, Chemical and Biological Sciences received 3566 citations as per google scholar report

International Journal of Pharmaceutical, Chemical and Biological Sciences peer review process verified at publons

ANTIOXIDANT AND ANTI TUMORAL ACTIVITIES OF HYDRAZYLPYRROLIDINE 2, 5 DIONE SUBSTITUTED AND 2-THIOXO IMIDAZOLIDINE 4-ONE

Abstract

Author(s): S. AichoucheBouzroura, L. Salhi, A. Belkebir , O. Ait-Yahia , A. Boudjlida3,S.BouguerraAouichat andB. NedjarKolli

In continuation of our research efforts toevaluate biological properties of synthesized compounds, we have investigated the in vitroantioxidant activity of hydrazylpyrrolidine 2, 5 dione substituted 2, 3and4or 2-thioxo imidazolidine 4-one5,6and7 by spectrophotometric DPPH and lipid peroxide inhibition. The IC50of both compounds was higher excepted compounds 6b, 7a and 4c witch have a low value (4.9, 6.18, 6.70 μg/mL) respectively.Thesecompounds exhibited strong antioxidant activity.Their IC50are approximatively equal to standard quercetin for4c and7a or to ascorbic acid standard for 6b. In vitrolipid peroxydation was determined by antioxidant activity using the β-Carotene/ linoleic acid system. The synthesis compounds have revealed a low or moderate antioxidant activity. The maximum relative antioxidant activity (AAR) was observed for derivatives 2a and7c respectively (53.31, 48.72 μg/mL). In vitro antitumoral activities of compounds 2a and 6b at 370 μg/mLhave exhibited significant antitumoral activities against HEp2(Human Laryngeal CarcinomaCells)

Get the App